Ping Ren

6.3k total citations · 1 hit paper
112 papers, 3.6k citations indexed

About

Ping Ren is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Ping Ren has authored 112 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 24 papers in Epidemiology and 17 papers in Molecular Biology. Recurrent topics in Ping Ren's work include SARS-CoV-2 and COVID-19 Research (22 papers), SARS-CoV-2 detection and testing (17 papers) and Fungal Infections and Studies (16 papers). Ping Ren is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (22 papers), SARS-CoV-2 detection and testing (17 papers) and Fungal Infections and Studies (16 papers). Ping Ren collaborates with scholars based in United States, China and Brazil. Ping Ren's co-authors include Pei‐Yong Shi, Brian P. Leaderer, Xuping Xie, Vishnu Chaturvedi, Michael B. Bracken, Jing Zou, Chaitanya Kurhade, Hongjie Xia, Vineet D. Menachery and Laura D. Kramer and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Ping Ren

103 papers receiving 3.5k citations

Hit Papers

Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Ren United States 30 1.9k 728 634 601 498 112 3.6k
Kelly J. Davis United States 32 2.4k 1.3× 921 1.3× 899 1.4× 368 0.6× 294 0.6× 71 4.6k
V. Kumaraswami India 41 3.1k 1.6× 596 0.8× 308 0.5× 597 1.0× 411 0.8× 106 4.5k
Eszter Nagy Austria 37 931 0.5× 716 1.0× 2.7k 4.3× 448 0.7× 290 0.6× 121 5.3k
Joon Wah Mak Malaysia 26 815 0.4× 219 0.3× 431 0.7× 686 1.1× 192 0.4× 207 2.8k
A. L. Jensen Denmark 39 238 0.1× 337 0.5× 865 1.4× 291 0.5× 281 0.6× 166 5.4k
E. J. Ruitenberg Netherlands 33 614 0.3× 785 1.1× 555 0.9× 413 0.7× 109 0.2× 162 3.7k
Paula Rahal Brazil 33 628 0.3× 890 1.2× 1.0k 1.7× 541 0.9× 66 0.1× 173 3.7k
Yanjun Zhang China 26 1.4k 0.7× 494 0.7× 735 1.2× 282 0.5× 71 0.1× 194 3.5k
Katsuhiko Kamei Japan 33 2.5k 1.3× 1.9k 2.6× 765 1.2× 102 0.2× 141 0.3× 322 4.6k
Julia Oh United States 35 695 0.4× 1.1k 1.5× 2.2k 3.5× 178 0.3× 140 0.3× 93 7.0k

Countries citing papers authored by Ping Ren

Since Specialization
Citations

This map shows the geographic impact of Ping Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Ren more than expected).

Fields of papers citing papers by Ping Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Ren. The network helps show where Ping Ren may publish in the future.

Co-authorship network of co-authors of Ping Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Ren. A scholar is included among the top collaborators of Ping Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Ren. Ping Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Yanping, Jing Zou, Jason Yeung, et al.. (2025). Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3. mBio. 16(6). e0350324–e0350324. 2 indexed citations
2.
Zou, Jing, et al.. (2025). A dual-reporter HCoV-OC43 for coronavirus biology and countermeasure development. Antiviral Research. 244. 106306–106306.
4.
Zhou, Beibei, P.L. Yu, Yonghong Bi, et al.. (2025). Synergistic regulation of Cd stress tolerance in Brassica juncea: Metabolic reprogramming and nutrient-Cd co-transport under Trichoderma harzianum and polyaspartic acid. Environmental Chemistry and Ecotoxicology. 7. 1386–1400.
5.
Reynoso, David, et al.. (2024). Complex trauma sequelae: Mycobacterium goodii and Priestia endophytica Hardware infection in a patient with Ehlers-Danlos syndrome. BMC Infectious Diseases. 24(1). 1064–1064. 2 indexed citations
6.
Shi, Yiwen, Ping Ren, Jing Wang, et al.. (2023). Leveraging GPT-4 for food effect summarization to enhance product-specific guidance development via iterative prompting. Journal of Biomedical Informatics. 148. 104533–104533. 18 indexed citations
7.
Zou, Jing, Chaitanya Kurhade, Yanping Hu, et al.. (2023). An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay. Viruses. 15(9). 1855–1855. 3 indexed citations
8.
Cao, Junling, Ping Ren, Jiali Chen, et al.. (2023). Network Pharmacology and Experimental Validation to Explore Mechanism of Tetrahydropalmatine on Acute Myocardial Ischemia. Chinese Journal of Integrative Medicine. 29(12). 1087–1098.
9.
Wang, Jing, et al.. (2023). Fine-tuning BERT for automatic ADME semantic labeling in FDA drug labeling to enhance product-specific guidance assessment. Journal of Biomedical Informatics. 138. 104285–104285. 13 indexed citations
10.
Kurhade, Chaitanya, Jing Zou, Hongjie Xia, et al.. (2022). Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nature Medicine. 29(2). 344–347. 251 indexed citations breakdown →
11.
Zou, Jing, Xuping Xie, Mingru Liu, Pei‐Yong Shi, & Ping Ren. (2022). Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections. mBio. 13(4). e0199622–e0199622. 7 indexed citations
12.
Zou, Jing, Chaitanya Kurhade, Hongjie Xia, et al.. (2022). Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2. Nature Communications. 13(1). 2956–2956. 22 indexed citations
13.
Liu, Yang, Xianwen Zhang, Jianying Liu, et al.. (2022). A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nature Communications. 13(1). 4337–4337. 62 indexed citations
14.
Machado, Rafael Rahal Guaragna, Brooke Mitchell, Allan McConnell, et al.. (2022). A Comparison of Seegene Technologies Novaplex SARS-CoV-2 Variants I, II, and IV Assays with Spike Gene Sequencing for Detection of Known Severe Acute Respiratory Syndrome Coronavirus 2 Variants. Journal of Molecular Diagnostics. 24(5). 455–461. 8 indexed citations
15.
Zou, Jing, Hongjie Xia, Xuping Xie, et al.. (2022). Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection. Nature Communications. 13(1). 852–852. 79 indexed citations
16.
Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2021). Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 12(1). 3984–3984.
17.
Muruato, Antonio E., Camila R. Fontes-Garfias, Ping Ren, et al.. (2021). Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature Communications. 12(1). 4000–4000. 1 indexed citations
18.
Muruato, Antonio E., Camila R. Fontes-Garfias, Ping Ren, et al.. (2020). A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature Communications. 11(1). 4059–4059. 207 indexed citations
19.
Xie, Xuping, Antonio E. Muruato, Xianwen Zhang, et al.. (2020). A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nature Communications. 11(1). 142 indexed citations
20.
Zheng, Rongjiong, et al.. (2017). Serum Uric Acid Levels and Risk of Incident Hypertriglyceridemia: A Longitudinal Population-based Epidemiological Study.. PubMed. 47(5). 586–591. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026